UNR844

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UNR844, covering 2023-08-30 to 2023-08-30. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia. [Phase 2]